Naproxen Dosing with Sumatriptan 100mg
When combining naproxen with sumatriptan (Imitrex) 100mg for acute migraine treatment, use naproxen sodium 500-550mg taken concomitantly with each dose of sumatriptan.
Recommended Dosing Strategy
The most recent and highest-quality evidence supports using naproxen sodium 500mg combined with sumatriptan 85-100mg as a single-dose regimen for acute migraine attacks 1. This combination targets multiple migraine mechanisms simultaneously and provides superior efficacy compared to either agent alone.
Specific Dosing Protocol
- Naproxen sodium: 500-550mg orally taken at the same time as sumatriptan 100mg
- Administer as soon as possible after migraine onset for optimal efficacy 1
- Maximum daily naproxen dose: 1,250mg on day 1, then 1,000mg/day thereafter 2
- Maximum sumatriptan dose: 200mg per 24 hours 3
Evidence Supporting This Combination
The combination approach is strongly supported by multiple lines of evidence:
Clinical efficacy data demonstrates that sumatriptan plus naproxen sodium significantly reduces migraine recurrence compared to sumatriptan alone—from 59-62.5% recurrence with sumatriptan monotherapy down to 14.2-25.5% with the combination 4. This represents a clinically meaningful improvement in sustained pain relief.
Recent guidelines from the American College of Physicians (2025) recommend adding a triptan to an NSAID for patients with moderate to severe migraine who don't achieve adequate relief with NSAIDs alone 1. The guideline specifically notes that combination therapy improves efficacy and should be initiated early in the attack.
Real-world effectiveness studies show the fixed-dose combination (sumatriptan 85mg/naproxen sodium 500mg) achieves 2-hour pain relief in 68.8% of attacks and functional recovery in 64.4% of attacks, with low rescue medication use (76.9% of attacks required no additional medication) 5.
Important Clinical Considerations
Timing Matters
Early treatment within 1 hour of migraine onset is associated with higher pain relief and functional recovery 5. Counsel patients to take the combination immediately when they recognize a migraine attack.
No Pharmacokinetic Interaction
Naproxen does not alter sumatriptan pharmacokinetics, so no dose adjustment is needed based on drug-drug interactions 6. The combination is safe from a pharmacokinetic standpoint.
Contraindications to Monitor
- Sumatriptan: Avoid in cardiovascular disease, uncontrolled hypertension, hemiplegic/basilar migraine, within 24 hours of ergotamines 7, 3
- Naproxen: Avoid in aspirin/NSAID-induced asthma, active GI bleeding, severe renal impairment 7, 2
Medication Overuse Headache Risk
Limit use to ≤10 days per month to prevent medication overuse headache 1, 8. If attacks occur more frequently, prophylactic therapy should be initiated rather than increasing acute medication frequency.
Alternative Formulations
For patients with severe nausea/vomiting, consider:
- Sumatriptan 6mg subcutaneous (faster onset, ~15 minutes to peak) 7 plus naproxen sodium 500mg orally
- Sumatriptan 20mg intranasal 7 plus naproxen sodium 500mg orally
The subcutaneous route achieves 70-82% efficacy and is the fastest-acting option when oral absorption may be compromised 7.
Pregnancy and Lactation
Both medications have concerns in pregnancy. Sumatriptan is Category C with evidence of embryolethality in animal studies 3. Naproxen should be avoided, particularly in the third trimester. For pregnant patients, acetaminophen remains the safest first-line option 8.